info@knollhealthcare.com
M17, Pharma Tower, Phase-1, Badli Industrial Area, Badli, Delhi, 110042
Sr. No. | Product Image | Product Name | PKG | Composition |
---|---|---|---|---|
1 | CEFAXIME-O DRY SYP (PET) | 30ML | EACH 5ML OF RECONSTITUTED SUSPENSION CONTAINS: CEFIXIME TRIHYDRATE 50MG | |
2 | C-FODE DRY SYP (PET) | 30ML | EACH 5ML OF RECONSTITUTED SUSP.CONTAINS:CEFPODOXIME 50MG | |
3 | M-CLAV D/S (PET) 30ML | 30ML | EACH 5 ML OF RECONSTITUTED SUSPENSION CONTAINS: AMOXYCILLIN TRIHYDRATE IP EQ. TO AMOXYCILLIN 200 MG, POTASSIUM CLAVULANTE DILUTED IP EQ. TO CLAVULANIC ACID 28.5 MG, IN A PALATABLE SUSPENSION BASE Q.S, COLOUR: TITANIUM DIOXIDE IP | |
4 | KAXIM DRY SYP 30ML | 30ML | EACH 5ML OF THE RECONSTITUTED SUSPENSION CONTAINS: CEFIXIME IP 50MG, EXCIPIENTS Q.S. IN A FLAVOURED SYRUP BASE COLOUR: SUNSET YELLOW FCF | |
5 | MOXINCLAV DRY SYP (GLASS) | 30ML | EACH 5 ML OF RECONSTITUTED SUSPENSION CONTAINS: AMOXYCILLIN TRIHYDRATE IP EQ. TO AMOXYCILLIN 200 MG, POTASSIUM CLAVULANTE DILUTED IP EQ. TO CLAVULANIC ACID 28.5 MG, IN A PALATABLE SUSPENSION BASE Q.S, COLOUR: TITANIUM DIOXIDE IP | |
6 | CEPDONOL-CV (GLASS BOTTLE WITH WATER) | 16X16X30 ML | EACH 5ML CONTAINS: CEFPODOXIME 50MG, CLAVULANIC ACID 31.25MG/5ML | |
7 | CIFIZA-O DRY SUSP. (GLASS BOTTLE, WITH WATER) | 1X30 ML | EACH 5ML. OF THE RECONSTITUTED SUSPENSION CONTAINS: CEFIXIME IP EQUIVALENT TO ANHYDROUS CEFIXIME 50MG, IN A PALATABLE SUSPENSION BASE Q.S, COLOUR: TITANIUM DIOXIDE IP. | |
8 | KNOLLCLAV-CV DRY SYP (GLASS BOTTLE WITH WATER) | 16X16X30 ML | EACH 5ML CONTAINS: AMOXICLAV THIHYDRATE 125MG, CLAUVLANIC 31.25MG, EXCIPIENTS Q.S, |
ABOVE MENTIONED PRODUCTS ARE AS PER THE BEST OF OUR KNOWLEDGE, HUMAN ERRORS CAN BE NEGLIGIBLE.